With a revenue increase of 39.53% in the second quarter 2026, year on year to cumulative value of $51 million, Coherus Oncology Inc 's revenue per employee grew on a trailing twelve months basis to $ 346,503. The productivity of Coherus Oncology Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 297 other companies have achieved higher revenue per employee. While Coherus Oncology Inc 's total ranking has deteriorated compared to the previous quarter from 2178 to 2428. Coherus Oncology Inc has 147 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CHRS Revenue per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Revenue Change	39.53 %	61.99 %	-76.46 %	-83.65 %	-84.22 %
Sales per Employee (TTM) $	346,503	318,932	286,884	568,490	971,231
CHRS's Total Ranking	# 2428	# 2178	# 2446	# 1471	# 2063
Seq. Revenue Change	16.22 %	-3.44 %	10.17 %	12.84 %	34.94 %

CHRS Company Profile >> Back to CHRS Efficiency Comparisons >> Compare CHRS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 37
Healthcare Sector	# 298
Overall Market	# 2428

Revenue per Employee Statistics
High	Average	Low
$ 3,328,306	$ 1,494,613	$ 179,156
(Sep 30 2020)		(Sep 30 2015)

Financial Statements
Coherus Oncology Inc 's Revenue MRQ	$ 14 Millions	Visit CHRS's Income Statement
Coherus Oncology Inc 's Revenues TTM	$ 51 Millions	Visit CHRS's aggregate revenue growth
What are CHRS's Sales?		Visit CHRS's Sales by Segment

Other Ratios
Coherus Oncology Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CHRS's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CHRS's Competitors
Revenue per Employee for CHRS's Suppliers
Revenue per Employee for CHRS's Customers

You may also want to know
CHRS's Sales Growth Rates	CHRS's Pe Price to earnings ratio	CHRS's Receivables Turnover Ratio	CHRS's Stock Quote
CHRS's Net Income Growth Rates	CHRS's Ps Price to Sales ratio	CHRS's Sales per Employee	CHRS's Asset Turnover Ratio
CHRS's Net Margin	CHRS's Pb Price to Book ratio	CHRS's Financial Strength Ratios	CHRS's Dividend Payout Ratio

Date modified: 2026-09-11T07:12:48+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 30 2026	Number of Employees Jun 30 2026
Delcath Systems Inc	602,935.90	$ 94.058 Million	156
Nephros Inc	602,388.89	$ 21.686 Million	36
Caredx Inc	598,809.15	$ 458.089 Million	765
Jaguar Health Inc	591,808.51	$ 27.815 Million	47
Milestone Scientific Inc	590,317.47	$ 8.855 Million	15
Waters Corporation	587,879.62	$ 4,644.249 Million	7,900
Phibro Animal Health Corporation	582,288.29	$ 1,516.861 Million	2,605
Rhythm Pharmaceuticals Inc	579,512.08	$ 239.918 Million	414
Macrogenics Inc	572,266.21	$ 167.674 Million	293
Si bone inc	570,029.26	$ 214.331 Million	376
Cardiff Lexington Corporation	567,380.00	$ 10.213 Million	18
Insulet Corporation	565,444.44	$ 3,053.400 Million	5,400
Novavax inc	552,464.62	$ 413.796 Million	749
Embecta Corp	551,189.19	$ 1,019.700 Million	1,850
Iridex Corp	548,860.22	$ 51.044 Million	93
Henry Schein Inc	544,080.00	$ 13,602.000 Million	25,000
Enanta Pharmaceuticals Inc	543,816.67	$ 65.258 Million	120
Editas Medicine Inc	540,287.36	$ 47.005 Million	87
Organogenesis Holdings Inc	535,660.42	$ 457.454 Million	854
Bausch Health Companies Inc	534,630.54	$ 10,853.000 Million	20,300
Instil Bio Inc	527,529.41	$ 8.968 Million	17
Globus Medical Inc	524,155.67	$ 3,144.934 Million	6,000
10x Genomics Inc	523,400.68	$ 616.566 Million	1,178
Ultragenyx Pharmaceutical Inc	523,130.56	$ 717.212 Million	1,371
Iradimed Corporation	520,114.23	$ 86.339 Million	166
Orthofix Medical Inc	519,217.45	$ 833.344 Million	1,605
Lexicon Pharmaceuticals Inc	511,962.96	$ 41.469 Million	81
Perrigo Company Plc	511,604.94	$ 4,144.000 Million	8,100
Butterfly Network Inc	510,727.27	$ 112.360 Million	220
Beone Medicines Ltd	510,686.50	$ 6,128.238 Million	12,000

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.